Evidence map›Paper›PMID 31358547›Full record

ArticleMolecular and cellular biology2019

Aryl Hydrocarbon Receptor Directly Regulates

Tomohiro Edamitsu, Keiko Taguchi, Eri H Kobayashi, Ryuhei Okuyama, Masayuki Yamamoto

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. AHR and NRF2 in Skin Homeostasis and Atopic Dermatitis.Antioxidants (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tomohiro EdamitsuDepartment of Medical Biochemistry, Tohoku University Graduate School of Medicine, Aoba, Sendai, Japan.
Keiko TaguchiDepartment of Medical Biochemistry, Tohoku University Graduate School of Medicine, Aoba, Sendai, Japan.
Eri H KobayashiDepartment of Medical Biochemistry, Tohoku University Graduate School of Medicine, Aoba, Sendai, Japan.
Ryuhei OkuyamaDepartment of Dermatology, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan.
Masayuki YamamotoDepartment of Medical Biochemistry, Tohoku University Graduate School of Medicine, Aoba, Sendai, Japan masiyamamoto@med.tohoku.ac.jp.
Tohoku University · JPShinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transgenic mice expressing a constitutively active form of the aryl hydrocarbon receptor in keratinocytes (AhR-CA mice) develop severe dermatitis that substantially recapitulates the pathology of human atopic dermatitis. The neurotrophic factor artemin (Artn) is highly expressed in the epidermis of AhR-CA mice and causes hypersensitivity to itch (alloknesis) by elongating nerves into the epidermis. However, whether the

Indexed as

Dermatitis, AtopicAir PollutantsAnimalsAntibodies, NeutralizingBasic Helix-Loop-Helix ProteinsEnhancer Elements, GeneticGene Expression RegulationHumansMethylcholanthreneMice, Inbred C57BLMice, TransgenicNerve Tissue ProteinsReceptors, Aryl HydrocarbonResponse ElementsSkinXenobioticsAhr protein, mouseAir PollutantsAntibodies, NeutralizingArtn protein, mouseBasic Helix-Loop-Helix ProteinsMethylcholanthreneNerve Tissue ProteinsReceptors, Aryl HydrocarbonXenobioticsAhRalloknesisarteminatopic dermatitisskin

Identifiers

PMID31358547
PMCPMC6766698
OpenAlexW2963786674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.